跳至主要内容
临床试验/NCT06105411
NCT06105411招募中不适用

Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions

Peter MacCallum Cancer Centre, Australia1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10
试验地点
1
主要终点
Uptake of radiolabelled siderophore (68Ga-TAFC) in patients with proven/probable invasive Aspergillosis

研究概览

简要总结

This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.

详细描述

This open label, single centre, proof of concept pilot imaging trial will evaluate technique for the diagnosis of invasive Aspergillus infection. It aims to demonstrate uptake of the gallium-siderophore tracer at sites of known proven/probable invasive aspergillus app infection. It will also assess the safety and tolerability of this technique.

10 patients within 2 weeks of proven or probable invasive fungal infection (IFI) diagnosis will be recruited to this study over a period of 12-24 months.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has provided written informed consent
  • Aged 18 years or older at written informed consent
  • Within 2 weeks of proven or probable or possible invasive fungal infection (IFI) diagnosis as per EORTC criteria
  • Imaging consistent with invasive pulmonary aspergillosis on CT or FDG-PET/CT with lesions at least 8mm in diameter
  • Patient is willing and able to comply with the protocol for the duration of the study including scheduled visits such as follow up

排除标准

  • Women who are pregnant or lactating.
  • Iron infusion within one week prior to scan

结局指标

主要结局

Uptake of radiolabelled siderophore (68Ga-TAFC) in patients with proven/probable invasive Aspergillosis

时间窗: At 60 minutes

The maximum standardized uptake value (SUVmax) is widely used for measuring the uptake of FDG by malignant tissue.

次要结局

  • Safety of 68Ga-TAFC-PET/CT(Evaluated within 24 hours of scan)
  • Findings compared to CT and/or 18F-FDG PET/CT(At 60 minutes)
  • Physiologic bio distribution(Evaluated up to 3 hours following injection of radiotracer)

研究者

发起方
Peter MacCallum Cancer Centre, Australia
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验